• Users Online: 58
  • Print this page
  • Email this page
VIEWPOINT
Year : 2018  |  Volume : 2  |  Issue : 2  |  Page : 152-157

Depot preparation in schizophrenia: Indian outlook


1 Consultant Psychiatrist, Unlimited Potentialities, Mumbai, Maharashtra, India
2 Department of Psychiatry, LTMMC and GH, Mumbai, Maharashtra, India

Correspondence Address:
Mohit Shah
603, Aura Biplex Senate, Above Kalyan Jewellers, Borivali West, Mumbai, Maharashtra
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/aip.aip_41_18

Rights and Permissions

Schizophrenia is a mostly chronic mental disorder, and symptomatic relapse is frequently observed. It is often associated with social and/or occupational decline that can be difficult to reverse. Most patients with the illness need long-term pharmacological treatment and antipsychotic drugs represent the mainstay of clinical care. Long-acting injectable antipsychotics are an important alternative to oral medication, particularly advantageous in the context of compliance management.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed26    
    Printed4    
    Emailed0    
    PDF Downloaded15    
    Comments [Add]    

Recommend this journal